Active development of rakes in $51.5 million to enhance development therapy models for autism
Active Development, a developmental therapy provider for children with autism, announced Wednesday that it raised $51.5 million in Series C funding.
According to Asport Development's website, the Virginia-based McLean company's model is based on development relationship-based interventions (DRBI), which focuses on mentoring and helping parents engage meaningfully with their children through “gentle, warm communication.” The model is designed to help children better communicate, learn, solve problems and regulate emotions.
As positive developments occur, patients and their families can use clinical support teams and parent support meetings as well as personalized care plans. Although center services are also available, most care is provided in the home. The company works with most major insurance companies including Aetna and UnitedHealthCare.
The C Series is led by Amoon, B Capital and Flare Capital Partners, including participation from Digitalis Ventures and HealthWorx from Carefirst’s Innovation and Investment Division. To date, positive development has raised more than $100 million.
“Actively developing the ability to improve outcomes and reduce total care costs with Amoon’s mission is the mission of working with outstanding companies that are advancing solutions that will transform healthcare and help people live healthier and better lives,” Amoon said in a statement in a statement. “Their unique development therapy model brings access and affordability to systems in desperate need of change, as well as a broad partnership with payers and Medicaid demonstrates their success.”
Active Development Co-founder and CEO Mike Suters said the financing will be used in some key areas. This includes expansion within existing geography and new geography. The company currently has locations in California, Oklahoma, Texas, Maryland, New Jersey, Florida and Illinois. Over the next few years, Suites expects its services to triple in existing locations and expands it to five to 10 states.
Suites said the company will also use funds to advance its technology and deepen partnerships with health programs and state Medicaid by expanding value-based payment models.
The diagnosis of autism is increasing dramatically. Currently, about 31 children in the United States suffer from autism. According to the suite, most providers use Applied Behavior Analysis (ABA) to treat people with autism, but the waiting time is longer each year, with children spending more than $50,000 a year.
“The market is yelling at clinically effective, cost-effective and scalable alternatives. We are in a unique position to help solve this problem,” he said.
“Differences are fundamental: ABA focuses on behavioral modification, while relationship-based interventions focus on building relationships and supporting natural development,” he added. “We focus on helping clients develop their unique strengths and abilities through trust relationships.”
Cortica is a company that provides ABA services, which also offers speech and speech therapy, occupational therapy, consulting and other services. It was recently co-led by Morgan Health and Nexus Neurotech Ventures.
Ultimately, positive development hopes to “make developmental therapy affordable to everyone everywhere and available.”
Photos: TAW4, Getty Images
